Upper Respiratory Tract Infection Clinical Trial
Official title:
Effetto Della Supplementazione di Una Miscela di Ceppi Probiotici (Bifidobacterium Breve M-16V, Bifidobacterium Lactis HN019, Lactobacillus Rhamnosus HN001) in Bambini Febbrili Con Infezioni Delle Alte Vie Respiratorie
The goal of this randomized non-pharmacological Intervention study is to evaluate the effects of probiotic supplements (Bifidobacterium breve M-16V, Bifidobacterium lactis HN019, Lactobacillus rhamnosus HN001) on children affected by upper respiratory tract infections. The main questions it aims to answer are: - probiotic formulation can reduce intensity and duration of fever in children affected by upper respiratory tract infections - probiotic formulation can influence the gut microbiota composition in children affected by upper respiratory tract infections Participants will be asked to take probiotic supplements or placebo for 14 days and to collect three fecal samples: before probiotic supplementation (T0), 14 days after probiotic supplementation (T1), and 12 months after the enrollment (T2).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04960878 -
The Effect of Synbiotics on the Upper Respiratory Tract Infection
|
N/A | |
| Terminated |
NCT00979667 -
A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection
|
Phase 3 | |
| Recruiting |
NCT04479657 -
Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection
|
Early Phase 1 | |
| Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
| Recruiting |
NCT06065176 -
The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection
|
Phase 4 | |
| Recruiting |
NCT01985620 -
The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate.
|
N/A | |
| Completed |
NCT01875757 -
Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life
|
Phase 3 | |
| Recruiting |
NCT00551382 -
Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children: a Randomised, Double-blind, Placebo-controlled Study
|
Phase 3 | |
| Completed |
NCT00393835 -
A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis
|
Phase 3 | |
| Not yet recruiting |
NCT05612893 -
Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study
|
||
| Completed |
NCT06149117 -
Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China
|
Phase 4 | |
| Active, not recruiting |
NCT05569330 -
Effect of Aerosol Filtering on Infectious Diseases in Day Care
|
N/A | |
| Recruiting |
NCT05374070 -
Antiviral Activity of Oral Probiotics
|
N/A | |
| Completed |
NCT00707941 -
Oseltamivir Randomised Controlled Efficacy Trial
|
Phase 3 | |
| Completed |
NCT00858494 -
Homeopathic Cold Medicine for Children
|
N/A | |
| Completed |
NCT04955327 -
To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI
|
Phase 3 | |
| Completed |
NCT01735084 -
Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life
|
Phase 4 | |
| Not yet recruiting |
NCT03461692 -
A Registry Study of 100 Thousand Cases of Pediatric Patients on Reduning Injection（a Chinese Medicine Injection）Used in Hospitals in China
|
N/A | |
| Completed |
NCT03011515 -
Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)
|
||
| Recruiting |
NCT05915390 -
Walnut and Immunity Study
|
N/A |